Literature DB >> 7760654

[Prognostic factors in curative resection of stomach carcinoma. A uni- and multivariate analysis].

J Gardovskis1, O Horstmann, C Ohmann, P R Verreet, Q Yang, R Wlasak, N Bösing, F Borchard, H D Röher.   

Abstract

The TNM system, including tumor infiltration (T category), lymph node infiltration (N category) and metastasis (M category), is a well-established system of prognostic factors. To evaluate the prognostic importance of patient characteristics and tumor parameters 5 clinical and 13 pathological factors were analyzed. Data on 200 consecutive patients with histologically verified stomach cancer were prospectively recorded using a standardized form. In the subgroup with curative resection (R0, n = 108) a uni- and multivariate analysis was performed with respect to 5-year survival. In the univariate analysis statistical significance was demonstrated for the following factors: tumor size, tumor localization, T category, N category, number of infiltrated lymph nodes infiltrated, lymph node compartments, tumor stage, lymph node ratio: infiltrated/inspected. Multivariate analysis, taking into consideration the interaction between prognostic factors, revealed only two factors as statistically significant: number of infiltrated lymph nodes and tumor size. Our results and those in the literature indicate that the infiltration of lymph nodes is the most relevant prognostic factor. In addition to the TNM system the number of infiltrated lymph nodes seems to be of prognostic importance.

Entities:  

Mesh:

Year:  1995        PMID: 7760654     DOI: 10.1007/BF00186412

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  18 in total

1.  [Prognostic factors in stomach cancer. Results of a uni- and multivariate analysis].

Authors:  K Böttcher; K Becker; R Busch; J D Roder; J R Siewert
Journal:  Chirurg       Date:  1992-08       Impact factor: 0.955

2.  Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer.

Authors:  S Moriguchi; Y Maehara; K Akazawa; K Sugimachi; Y Nose
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

3.  Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.

Authors:  S Abe; M Shiraishi; S Nagaoka; H Yoshimura; D K Dhar; T Nakamura
Journal:  Surgery       Date:  1991-05       Impact factor: 3.982

4.  Lymph node involvement as the only prognostic factor in curative resected gastric carcinoma: a multivariate analysis.

Authors:  S Msika; C Chastang; S Houry; F Lacaine; M Huguier
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

5.  Prognostic grouping: the next step in tumor classification.

Authors:  P Hermanek; R V Hutter; L H Sobin
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  The natural history of gastric cancer and prognostic factors influencing survival.

Authors:  A Y Bedikian; T T Chen; N Khankhanian; L K Heilbrun; C M McBride; M J McMurtrey; G P Bodey
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

7.  [Normal value of the number of lymph nodes in the epigastrium. An anatomic study for lymphadenectomy in stomach cancer].

Authors:  P K Wagner; A Ramaswamy; H Sitter; J Rüschoff; P Schmitz-Moormann
Journal:  Chirurg       Date:  1990-04       Impact factor: 0.955

8.  Prognostic factors in adenocarcinoma in the upper one-third of the stomach.

Authors:  Y Maehara; S Moriguchi; Y Kakeji; H Orita; M Haraguchi; D Korenaga; K Sugimachi
Journal:  Surg Gynecol Obstet       Date:  1991-09

9.  Relation of proliferative activity to survival in patients with gastric carcinoma.

Authors:  Y Tonemura; T Kamata; S Ooyama; K Sugiyama; H Kimura; T Kosaka; A Yamaguchi; I Miyazaki
Journal:  J Surg Oncol       Date:  1990-01       Impact factor: 3.454

Review 10.  [Surgical treatment of stomach cancer].

Authors:  H J Meyer; J Jähne; H Wilke; R Pichlmayr
Journal:  Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.